Co. withdrew the painkiller Vioxx from the market last September after the drug was linked to increased risks of heart attack and stroke, more than one metabolomics researcher shook their heads and ...

During the period the drug was in the market, Merck's direct-to-consumer advertising of Vioxx was intense despite the growing concerns with its safety profile, likely increasing consumption of the ...